MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/mr/roaf042

Медицинская библиотека · Modern rheumatology · 2025

Recommendations for the treatment of juvenile idiopathic arthritis with oligoarthritis or polyarthritis from the 2024 update of the Japan College of Rheumatology Clinical Practice Guidelines for the management of rheumatoid arthritis including juvenile idiopathic arthritis with oligoarthritis or polyarthritis - secondary publication.

Miyamae Takako, Okamoto Nami, Inoue Yuzaburo, Kubota Tomohiro, Ebato Takasuke, Irabu Hitoshi, Kameda Hideto, Kaneko Yuko, Kubo Hiroshi, Mitsunaga Kanako, Mori Masaaki, Nakajima Ayako, Nishimura Kenichi, Ohkubo Naoaki, Sato Tomomi, Sugita Yuko, Takanashi Satoshi, Tanaka Takayuki, Umebayashi Hiroaki, Yashiro Masato, Yamanishi Shingo, Fusama Mie, Hirata Shintaro, Kishimoto Mitsumasa, Kohno Masataka, Kojima Masayo, Kojima Toshihisa, Morinobu Akio, Sugihara Takahiko, Tanaka Eiichi, Yajima Nobuyuki, Yanai Ryo, Kawahito Yutaka, Harigai Masayoshi

СтатьяКлинические рекомендацииПеревод в очереди

Аннотация

OBJECTIVES

To conduct systematic reviews (SRs) and develop clinical practice guidelines (CPGs) for managing juvenile idiopathic arthritis (JIA) with oligoarthritis or polyarthritis.

METHODS

The Grading of Recommendations, Assessment, Development, and Evaluation methodology was employed to carry out SRs and formulate the CPGs. An expert panel, including patients, paediatric and nonpaediatric rheumatologists, guideline specialists, and patient representatives, used the Delphi method to discuss and agree on the recommendations.

RESULTS

Six clinical questions (CQs) on the efficacy and safety of medical treatments were evaluated. These included CQ1 on methotrexate (MTX), CQ2 on non-MTX conventional synthetic disease-modifying antirheumatic drugs, CQ3 on glucocorticoids, CQ4 on tumour necrosis factor inhibitors, CQ5 on interleukin-6 inhibitors, and CQ6 on Janus kinase inhibitors. Two randomized controlled trials were identified for CQ1, three for CQ2, two for CQ3, eight for CQ4, two for CQ5, and two for CQ6. Based on these evaluations, three strong and three conditional recommendations were established. The CPGs have been endorsed by the Japan College of Rheumatology and the Pediatric Rheumatology Association of Japan.

CONCLUSIONS

The SRs provided the necessary evidence to develop the CPGs, which are intended to guide not only paediatric but also nonpaediatric rheumatologists, caregivers, patients, and their families in treatment decision-making.

Для цитирования: Miyamae Takako, Okamoto Nami, Inoue Yuzaburo, Kubota Tomohiro, Ebato Takasuke, Irabu Hitoshi, Kameda Hideto, Kaneko Yuko, Kubo Hiroshi, Mitsunaga Kanako, Mori Masaaki, Nakajima Ayako, Nishimura Kenichi, Ohkubo Naoaki, Sato Tomomi, Sugita Yuko, Takanashi Satoshi, Tanaka Takayuki, Umebayashi Hiroaki, Yashiro Masato, Yamanishi Shingo, Fusama Mie, Hirata Shintaro, Kishimoto Mitsumasa, Kohno Masataka, Kojima Masayo, Kojima Toshihisa, Morinobu Akio, Sugihara Takahiko, Tanaka Eiichi, Yajima Nobuyuki, Yanai Ryo, Kawahito Yutaka, Harigai Masayoshi. Recommendations for the treatment of juvenile idiopathic arthritis with oligoarthritis or polyarthritis from the 2024 update of the Japan College of Rheumatology Clinical Practice Guidelines for the management of rheumatoid arthritis including juvenile idiopathic arthritis with oligoarthritis or polyarthritis - secondary publication.. Modern rheumatology. 2025. DOI: 10.1093/mr/roaf042.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.